Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 19;18(5):e1010118.
doi: 10.1371/journal.pcbi.1010118. eCollection 2022 May.

CystiHuman: A model of human neurocysticercosis

Affiliations

CystiHuman: A model of human neurocysticercosis

Gabrielle Bonnet et al. PLoS Comput Biol. .

Abstract

Introduction: The Taenia solium tapeworm is responsible for cysticercosis, a neglected tropical disease presenting as larvae in the body of a host following taenia egg ingestion. Neurocysticercosis (NCC), the name of the disease when it affects the human central nervous system, is a major cause of epilepsy in developing countries, and can also cause intracranial hypertension, hydrocephalus and death. Simulation models can help identify the most cost-effective interventions before their implementation. Modelling NCC should enable the comparison of a broad range of interventions, from treatment of human taeniasis (presence of an adult taenia worm in the human intestine) to NCC mitigation. It also allows a focus on the actual impact of the disease, rather than using proxies as is the case for other models.

Methods: This agent-based model is the first model that simulates human NCC and associated pathologies. It uses the output of another model, CystiAgent, which simulates the evolution of pig cysticercosis and human taeniasis, adding human and cyst agents, including a model of cyst location and stage, human symptoms, and treatment. CystiHuman also accounts for delays in the appearance of NCC-related symptoms. It comprises three modules detailing cyst development, seizure probability and timing, and intracranial hypertension/hydrocephalus, respectively. It has been implemented in Java MASON and calibrated in three endemic villages in Peru, then applied to another village (Rica Playa) to compare simulation results with field data in that village.

Results and discussion: Despite limitations in available field data, parameter values found through calibration are plausible and simulated outcomes in Rica Playa are close to actual values for NCC prevalence and the way it increases with age and cases with single lesions. Initial simulations further suggest that short-term interventions followed by a rapid increase in taeniasis prevalence back to original levels may have limited impacts on NCC prevalence.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Risk of developing cysts in the encephalus following egg ingestion.
Fig 2
Fig 2. Timeline and symptoms associated with an NCC lesion.
Fig 3
Fig 3. Links between variations in human taeniasis prevalence and variations in NCC prevalence.
Note: the overall time scale is 192 years, or 10,000 weeks. One data point is represented for every 10 weeks (hence 1000 data points are represented here). The red arrows relate to specific zones of the graph that are discussed in the text.

Similar articles

Cited by

References

    1. Debacq G, Moyano LM, Garcia HH, Boumediene F, Marin B, Ngoungou EB, et al.. Systematic review and meta-analysis estimating association of cysticercosis and neurocysticercosis with epilepsy. PLoS neglected tropical diseases. 2017;11(3):e0005153. doi: 10.1371/journal.pntd.0005153 - DOI - PMC - PubMed
    1. Bruno E, Bartoloni A, Zammarchi L, Strohmeyer M, Bartalesi F, Bustos JA, et al.. Epilepsy and neurocysticercosis in Latin America: a systematic review and meta-analysis. PLoS neglected tropical diseases. 2013;7(10):e2480. doi: 10.1371/journal.pntd.0002480 - DOI - PMC - PubMed
    1. García HH, Gonzalez AE, Evans CAW, Gilman RH, Cysticercosis Working Group in P. Taenia solium cysticercosis. The Lancet. 2003;362(9383):547–56. - PMC - PubMed
    1. Carpio A. Neurocysticercosis: an update. The Lancet Infectious Diseases. 2002;2(12):751–62. doi: 10.1016/s1473-3099(02)00454-1 - DOI - PubMed
    1. Garcia HHMDP. Neurocysticercosis. Neurologic Clinics. 2018;36(4):851–64. doi: 10.1016/j.ncl.2018.07.003 - DOI - PubMed

Publication types